| BCBS Minnesota | Evaluation Process for New FDA-Approved Medical Drugs or Medical Drug Indications | 2025-03-31 |
| BCBS Minnesota | Autonomic Nervous System Function Testing | 2025-03-31 |
| BCBS Minnesota | Occipital Nerve Stimulation | 2025-03-31 |
| BCBS Minnesota | Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Myeloproliferative Neoplasms | 2025-03-31 |
| BCBS Minnesota | Hematopoietic Stem Cell Transplantation for Miscellaneous Solid Tumors in Adults | 2025-03-31 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Contraceptive Management | 2025-03-31 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Brentuximab Vedotin (Adcetris) | 2025-03-31 |
| BCBS Highmark Penn Medicare Advantage | Panitumumab (Vectibix) | 2025-03-31 |
| BCBS Highmark Penn Medicare Advantage | Brentuximab Vedotin (Adcetris) | 2025-03-31 |
| BCBS Highmark NY and West NY | Contraceptive Management | 2025-03-31 |